Certain glucose-lowering meds associated with lower risk for COPD exacerbations
For sufferers with kind 2 diabetes (T2D) and persistent obstructive pulmonary dysfunction (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 ...